Lv41
660 积分 2024-03-12 加入
Early biologic therapy and reduced acute healthcare utilization in hidradenitis suppurativa: A real-world analysis using TriNetX
26天前
已完结
Golimumab in Treatment-Refractory Hidradenitis Suppurativa
26天前
已完结
Therapeutic Infliximab Levels Are Associated With Improved Clinical Outcomes in Hidradenitis Suppurativa: A Pilot Retrospective Cohort Study
26天前
已完结
GLP-1 Receptor Agonist Use and Clinical Outcomes in Patients With Hidradenitis Suppurativa
26天前
已完结
GLP-1 Receptor Agonists in Hidradenitis Suppurativa—Emerging Opportunities for Comorbidity Management?
26天前
已完结
Repeated switching between biosimilar ABP 654 and reference ustekinumab in patients with moderate-to-severe plaque psoriasis: a randomized, double-blinded clinical trial to support interchangeability
2个月前
已完结
Pregnancy Outcomes in Biologic-Exposed Psoriasis Patients: A Large Cohort Study of Real-World Safety
2个月前
已完结
AI-Powered Imaging for Objective Psoriasis Severity Assessment at Home: Feasibility and Reliability in a Randomized Clinical Trial
2个月前
已完结
Drug survival of bimekizumab, guselkumab, and risankizumab after secondary IL‐17 inhibitor failure
2个月前
已完结
Clinical utility of immune biomarker staining of skin biopsies in psoriasis and eczematous dermatitis: A single-center retrospective analysis
2个月前
已完结
皖公网安备34019202002308
